HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
B Hermes Selected Research
B Hermes Research Topics
Disease
2
Pain (Aches)
02/2008 - 01/2001
2
Mastocytosis
09/2003 - 11/2001
2
Cicatrix (Scar)
03/2001 - 01/2000
1
Borderline Personality Disorder (Personality Disorders, Borderline)
04/2008
1
Body Dysmorphic Disorders (Body Dysmorphic Disorder)
02/2008
1
Somatoform Disorders (Somatoform Disorder)
02/2008
1
Buschke-Lowenstein Tumor
01/2007
1
Scabies (Sarcoptic Mange)
01/2005
1
Urticaria (Hives)
03/2003
1
Lymphoma (Lymphomas)
02/2002
1
Vasculitis (Vasculitides)
11/2001
1
Epidermodysplasia Verruciformis
10/2001
1
Hypopigmentation (Hypomelanosis)
04/2001
1
Hyperpigmentation
04/2001
1
Hyperplasia
03/2001
1
Neuralgia (Stump Neuralgia)
01/2001
1
Herpes Zoster
01/2001
1
Postherpetic Neuralgia
01/2001
1
Alopecia Areata
05/2000
Drug/Important Bio-Agent (IBA)
3
Stem Cell Factor
IBA
09/2003 - 01/2000
2
Nerve Growth Factor (NGF)
IBA
03/2003 - 03/2001
2
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
03/2003 - 03/2001
2
Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)
IBA
03/2001 - 01/2000
2
Avidin
IBA
03/2001 - 01/2000
1
Plastics
IBA
02/2008
1
Antibodies
IBA
01/2005
1
Antigens
IBA
01/2005
1
Immunoglobulin G (IgG)
IBA
01/2005
1
Alkaline Phosphatase
IBA
03/2003
1
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
03/2003
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
03/2003
1
Complement System Proteins (Complement)
IBA
11/2001
1
Fibrin
IBA
11/2001
1
A-factor (Streptomyces)
IBA
11/2001
1
Amiodarone (Amiodarona)
FDA Link
Generic
04/2001
1
Chemotactic Factors
IBA
03/2001
1
Tablets
IBA
01/2001
1
Antiviral Agents (Antivirals)
IBA
01/2001
1
Fas Ligand Protein (Fas Ligand)
IBA
05/2000
1
Tryptases (Tryptase)
IBA
01/2000
1
Chymases (Chymase)
IBA
01/2000
1
Enzymes
IBA
01/2000
1
Messenger RNA (mRNA)
IBA
01/2000
Therapy/Procedure
2
Therapeutics
04/2008 - 01/2007
1
Radiotherapy
02/2002
1
Highly Active Antiretroviral Therapy (HAART)
10/2001